We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
ARDX

Price
5.01
Stock movement up
+0.05 (1.01%)
Company name
Ardelyx Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
1.21B
Ent value
1.37B
Price/Sales
4.79
Price/Book
7.63
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-28.61%
1 year return
-15.08%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-10-30

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ARDX does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales4.79
Price to Book7.63
EV to Sales5.44

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count240.98M
EPS (TTM)-
FCF per share (TTM)-

Income statement

Loading...
Income statement data
Revenue (TTM)-
Gross profit (TTM)-
Operating income (TTM)-
Net income (TTM)-
EPS (TTM)-
EPS (1y forward)0.13

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash42.72M
Net receivables76.61M
Total current assets367.99M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets486.17M
Accounts payable18.39M
Short/Current long term debt207.61M
Total current liabilities83.39M
Total liabilities331.89M
Shareholder's equity154.28M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-
Capital expenditures (TTM)-
Free cash flow (TTM)-
Dividends paid (TTM)-

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-
Return on Invested Capital-
Cash Return on Invested Capital-

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.95
Daily high5.11
Daily low4.92
Daily Volume5.98M
All-time high32.89
1y analyst estimate11.73
Beta0.54
EPS (TTM)-
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ARDXS&P500
Current price drop from All-time high-84.77%-1.10%
Highest price drop-90.03%-19.00%
Date of highest drop14 May 20258 Apr 2025
Avg drop from high-84.54%-2.76%
Avg time to new high-5 days
Max time to new high266 days89 days
COMPANY DETAILS
ARDX (Ardelyx Inc) company logo
Marketcap
1.21B
Marketcap category
Small-cap
Description
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. Ardelyx, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
Employees
395
Investor relations
-
SEC filings
CEO
Michael G. Raab
Country
USA
City
Fremont
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...